Recursion Pharmaceuticals (RXRX) Debt to Equity (2020 - 2026)
Recursion Pharmaceuticals (RXRX) reported Debt to Equity of $0.02 for Q1 2026, down 40.13% on a YoY basis from $0.03 in Q1 2025, and down 2.71% quarter-over-quarter from $0.02 in Q4 2025.
Recursion Pharmaceuticals (RXRX) Debt to Equity (2020 - 2026) Analysis & Trends
Recursion Pharmaceuticals has reported Debt to Equity for 7 years, with the latest figure at $0.02 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity fell 40.13% year-over-year to $0.02; the trailing twelve-month figure through Mar 2026 stood at $0.02 (down 40.13% YoY), and the FY2025 full-year result was $0.02, down 37.81% from the prior year.
- Debt to Equity for Q1 2026 stood at $0.02, down from $0.02 in the prior quarter.
- The five-year high for Debt to Equity was $0.05 in Q3 2024, with the low at $0.0 in Q4 2022.
- Historically, Debt to Equity has averaged $0.02 across 5 years, with a median of $0.0 in 2023.
- Annual changes were most pronounced in 2022 — Debt to Equity slumped 90.87% — and 2024, when it jumped 2055.72%.
- Recursion Pharmaceuticals' Debt to Equity stood at $0.0 in 2022, then soared by 123.34% to $0.0 in 2023, then surged by 976.39% to $0.03 in 2024, then sank by 37.81% to $0.02 in 2025, then retreated by 2.71% to $0.02 in 2026.
- The last three Debt to Equity figures came in at $0.02 (Q1 2026), $0.02 (Q4 2025), and $0.02 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.01 |